LivePerson, Inc. Securities Lawsuit Investigation
On March 15, 2023, after the market closed, LivePerson, Inc. (NASDAQ: LPSN) reported disappointing fourth-quarter earnings results as Medicare suspended reimbursements to one of LivePerson’s subsidiaries “pending further governmental review.”
Following the unexpected drop in revenue, LivePerson’s stock price dropped 57% on March 16, 2023, causing significant harm to investors.
Lost Money in LivePerson Stock?
You may be eligible to recover your losses. Get a free and confidential consultation.
(Please provide number of shares, purchase date, and estimated losses.)
Why is LPSN stock dropping?
On Thursday, March 16, 2023, shares of customer service technology company LivePerson, Inc. dropped after the company published its fourth-quarter earnings results, showing both a revenue decline and earnings miss. The Company also disclosed that Medicare suspended reimbursements for WildHealth, one of its subsidiaries, “pending further governmental review.” LivePerson stated “[w]hile the Company currently believes that the services rendered under the Program in the fourth quarter of 2022 were valid, in view of the inherent uncertainty as to the timing and amount of further reimbursement for services rendered under the Program, the Company has elected to take a reserve for revenue associated with services delivered under the Program in the fourth quarter of 2022 for which payment has not been collected.”
Previously, on February 28, 2023, the day before the company was supposed to file its fourth-quarter earnings results, LivePerson filed an extension with the SEC to delay its 10-K report until March 16, 2023. LivePerson stated the reason for the delay was related to its acquisition of precision healthcare company WildHealth for $22 million last year and said it needed to conduct additional review of revenue recognition.
Our Securities Lawyers Have a Winning Record Against Companies Like LivePerson, Inc.
Our securities lawyers have recovered over a billion dollars on behalf of our clients against behemoths, such as Chase Bank, Mastercard, and Anthem Blue Cross Blue Shield. Read more about our results.
You “shouldn’t presume that powerful banks and other powerful interests can just get away with doing bad things. Good, qualified counsel that are committed to a cause can usually figure out how to prosecute such cases effectively and prevail.”
–Eric Gibbs, award-winning securities attorney
Praise from the Courts
Federal judge in our AT&T class action:
“I’ve always found them to be extraordinary counsel in terms of their preparation and their professionalism.”
Federal judge in our Chase lawsuit (resulting in $100 million settlement):
They “fought tooth and nail, down to the wire” to achieve “the best settlement that they could under the circumstances.”
Read more about what judges say about us.
Our Featured Securities Team
Eileen Epstein Carney
Eileen represents investors and consumers harmed by financial fraud and other corporate misconduct. She also executes on the firm's strategic vision.
View full profileDave Stein
Dave represents clients in cases nationwide, ranging from securities and financial fraud cases to product liability, privacy, and data breach suits.
View full profileCatherine Conroy
Catherine is dedicated to working with people who speak up and advocate for change. She helps oversee the litigation assistant team and is currently studying the law as an apprentice.
View full profileGibbs Law Group's Financial Fraud Experience
We have fought some of the most complex cases brought under federal and state laws nationwide, and our attorneys have been recognized with numerous awards and honors for their accomplishments, including Top 100 Super Lawyers in Northern California, Top Plaintiff Lawyers in California, The Best Lawyers in America, and rated AV Preeminent (among the highest class of attorneys for professional ethics and legal skills).